Niu Liu

Niu (Chris) Liu is a Senior Analyst at RTW Investments, LP in New York, where he specializes in biotechnology and life sciences, with a primary focus on oncology research and coverage of life sciences companies in China. His role centers on identifying and evaluating innovative biomedical therapies and companies, leveraging substantial sector expertise to guide investment decisions and portfolio management in these domains.

Chris's career background includes progressive roles at RTW Investments, starting as a research intern, advancing to research analyst, and now serving as senior analyst. Prior to joining RTW, he gained significant industry experience in business development at GenScript, primarily working on antibody drug discovery, development, and the design of CAR constructs for leading CAR-T companies including Kite, Juno, and Bellicum.

He holds a Ph.D. in Biochemistry from Stony Brook University, a BS in Chemistry from Fudan University, and an MBA in Finance and Management from NYU Stern School of Business. Dr. Liu is recognized for his expertise at the intersection of science and finance, providing critical insights that support RTW’s investment strategies in innovative healthcare sectors.